Left ventricular assist devices (LVADs) have become an increasingly common advanced
therapy in patients with severe symptomatic heart failure. Their unique nature in prolonging …

Patients with HF have tremendous PC needs across the spectrum of disease. Despite this,
more data are needed to determine the optimal timing and structure of PC interventions in …

As patients live longer with left ventricular assist device (LVAD) support, many will either
suffer an acute event or develop a gradual, progressive disease that results in a terminal …

The role of the mechanical circulatory support (MCS) coordinator, also known as the
ventricular assist device (VAD) coordinator, is a fluid position with changing roles and …

Background: Heart failure is a common life-limiting disease. A destination therapy for people
who will not have a heart transplant is a left ventricular assist device. Aims: To discover how …

Health care providers face a unique set of decision-making, assessment, and equipment
challenges at the end of life of patients supported with a left ventricular assist device. The …

Nurses who care for patients with a left ventricular assist device (LVAD) are highly skilled
clinicians who manage unique technological demands and complex complications within …

Left ventricular assist devices (LVADs) have become the standard of care for end-stage
heart failure refractory to medical therapy (Peura et al., Circulation (New York, NY) 126 …

Over the last decade, patients who remain critically ill but in the chronic stage have become
a subset of patients who often remain in the cardiac intensive care unit (CICU) for many …